App-Quantinova.ai

Utility Of Pre-Chemotherapy Echocardiograms

John Allen Steuter - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Heart muscle disease

Doxorubicin

Association Of Cardiac Iron By T2* With Innate Immune Markers In Transfusion-Dependent Thalassemia Patients Undergoing Combined Chelation Therapy

Patrick B Walter - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

Deferoxamine

Barth Syndrome and Neutropenia

David C. Dale - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Heart muscle disease

Filgrastim

Congestive Heart Failure (CHF) During Induction In ACUTE Promyelocytic Leukemia (APL) Patients

Arati Rani Chand - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Heart muscle disease

Idarubicin Hydrochloride

Final Report Of Phase II Study Of Sorafenib and 5-Azacytidine In Patients With Relapsed Or Untreated Acute Myeloid Leukemia and FLT3-ITD mutation

Maro Ohanian - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

5-Azacytidine

Cardiac Failure In Juvenile Rats Caused By Continuous Long-Term Exposure To The Tyrosine Kinase Inhibitor Dasatinib Can Be Circumvented By An Intermittent Application Schedule

Paula Geidel - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

dasatinib

DNA Methylation Changes In Patients With Chronic Lymphocytic Leukemia Relapsing After Treatment Are Not Stochastic But Rather Selectively Affect Critical Pathways For B-Cell Physiology

Nikos Papakonstantinou - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Bendamustine

The Clinical Significance Of Diastolic Dysfunction On The Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Naoki Shingai - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Heart muscle disease

N/A

Carfilzomib, Rituximab and Dexamethasone (CaRD) Is Highly Active and Offers a Neuropathy Sparing Approach For Proteasome-Inhibitor Based Therapy In Waldenstroms Macroglobulinemia

Steven P Treon - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Heart muscle disease

Dexamethasone

VWF Multimer Quantitation for Assessment of Cardiac Lesion Severity and Bleeding Risk

Justin Bryan - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Cardiac Events in Real-World Multiple Myeloma Patients Treated with Carfilzomib: A Retrospective Claims Database Analysis

Ajai Chari - American Society of Hematology (ASH) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Heart muscle disease

carfilzomib Intravenous

TREATMENT-NAVE, EARLY RHEUMATOID ARTHRITIS PATIENTS DEMONSTRATE VASCULAR AND MYOCARDIAL ABNORMALITIES ON CARDIAC MRI

B. Erhayiem - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

N/A

DETERMINANTS OF SURVIVAL OF FETUSES WITH AUTOIMMUNE CONGENITAL HEART BLOCK AND FACTORS ASSOCIATED WITH NEONATAL AND LATE-ONSET DILATED CARDIOMYOPATHY: 214 CASES FROM THE FRENCH REGISTRY OF NEONATAL LUPUS

K. Levesque - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

Hydroxychloroquine

SYSTEMIC SCLEROSIS-LIKE HISTOPATHOLOGICAL FEATURES IN THE MYOCARDIUM OF UPAR-DEFICIENT MICE

M. Manetti - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

N/A

THE ROLE OF THE MYELOID INFLAMMATORY BONE MARROW COMPARTMENT IN ONSET AND PROGRESSION OF MYOCARDIAL FIBROSIS IN SYSTEMIC SCLEROSIS

V. Haunerdinger - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Heart muscle disease

DE-074

OUTCOME OF THE AUTOIMMUNE CONGENITAL HEART BLOCK IN 45 BABIES FROM ANTI-RO/LA (+) MOTHERS: RESULTS FROM THE SPANISH REGISTRY (REBACC-GEAS-SEMI)

P. Brito Zeron - European League Against Rheumatism (EULAR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Dexamethasone

DISTINCT IMAGING PATTERNS OF HEART FAILURE IN SYSTEMIC LUPUS ERYTHEMATOSUS: EVALUATION USING CARDIOVASCULAR MAGNETIC RESONANCE

S. Mavrogeni - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

N/A

INFLAMMATORY-DRIVEN MYOCARDIAL FIBROSIS THE ROLE OF INFLAMMATORY PROGENITORS

G. Kania - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Nitric oxide

CARDIAC AND CARDIOVASCULAR MORBIDITIES IN PATIENTS WITH PSORIATIC ARTHRITIS: A POPULATION-BASED COHORT STUDY

A. Kibari - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Heart muscle disease

N/A

RECURRENT PERICARDITIS IN CHILDREN AND ADOLESCENTS: A LARGE, MULTICENTRIC CASE-SERIES AND IMPLICATIONS FOR THE PEDIATRIC RHEUMATOLOGIST

C. Di Blasi Lo Cuccio - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

Colchicine

Filters

3340 Abstracts